To determine if we could recapitulate this dynamic regulation of EZH2 in response to PI3K inactivation in AML cell lines, we treated NOMO1 and MOLM14 cells with copanlisib over the course of two days. Here, PIK3CB is linked to acute myeloid leukemia.